Newmed Energy

NewMed Energy completed its Series B bond offering with 2.4 billion NIS in demand, raising 1.751 billion NIS to fund Leviathan Phase B, Aphrodite, and debt repayment.

NewMed Energy, the energy partnership owned by the billionaire, has received exceptional trust from institutional entities in Israel and will issue a new series of long-term bonds that will support the development of the second phase of its flagship project.

The partnership controlled by Delek Group reported strong second-quarter 2026 results. The completion of the third pipeline and the INGL underwater section is expected to increase production and export capacity starting next quarter.

This month, Delek Group distributed to its shareholders, as a dividend in kind, the shares of its subsidiary (100%) Delek Yezum. The only asset of Delek Yezum is the right to receive overriding royalties from the revenues of NewMed Energy from the Leviathan reservoir.

Niv Sarne, who took office as chairman of NewMed Energy on June 1, will replace Yossi Abu as CEO early next week. Abu has led the company for the past 15 years.